A phase II trial of the epothilone B analog ixabepilone (BMS-247550) in patients with metastatic melanoma.

A phase II trial of the epothilone B analog ixabepilone (BMS-247550) in patients with metastatic melanoma.

Ixabepilone (BMS-247550), an epothilone B analog, is a microtubule stabilizing agent which has shown activity in several different tumor types and preclinical models in melanoma. In an open label, one-arm, multi-center phase II trial the efficacy and toxicity of this epothilone was investigated in t...

Full description

Bibliographic Details
Main Authors: Patrick A Ott, Anne Hamilton, Amanda Jones, Naomi Haas, Tsiporah Shore, Sandra Liddell, Paul J Christos, L Austin Doyle, Michael Millward, Franco M Muggia, Anna C Pavlick
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2010-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC2808339?pdf=render

Internet

http://europepmc.org/articles/PMC2808339?pdf=render

Similar Items